anti-Anti-CD20 (Rituximab), Chimeric Antibody
Catalog number
A1049-100
Name
anti-Anti-CD20 (Rituximab), Chimeric Antibody
Size
Anti-CD20 (Rituximab), Chimeric Antibody
Price
371.00 EUR
Supplier
Details
Target of this antibody:
CD20
Alternative names of antibody target:
MabThra
Background information:
Rituximab, a chimeric monoclonal antibody targeted against the pan-B-cell marker CD20. Mechanisms of cell destruction that have been demonstrated to be activated by rituximab binding to CD20 include direct signaling of apoptosis, complement activation and antibody dependent cellular cytotoxicity. Rituximab is a mainstay in the therapy for a broad variety of B-cell malignancies.
Antibody host:
Human/Mouse chimeric
Clonality of antibody:
Monoclonal
Isotype:
Human IgG1
This antibody reacts with:
Human
Immunogene sequence:
CD20
Concentration of antibody:
2 mg/ml
Form of antibody:
Liquid
Formulation of this antibody:
100 ug (2mg/ml) of antibody in Phosphate buffered saline, pH 7.4.
Purification method:
human IgG1 was expressed in a human cell line. IgG was purified from CHO cell culture supernatant by protein A chromatography.
This antibody has been succesfully tested for use in following methods:
Neutralization, ELISA
Recommended usage:
Activation : 1-20 μg/ml; ELISA: 2μg/ml
Storage information:
Shelf time: 12 months in temp.: -20 deg.C
Shipping conditions:
gel pack
How to handle this antibody:
The antibody solution should be gently mixed before use
Description
This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.
Properties
If you buy Antibodies supplied by Biovision they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
French translation
anticorps
